Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Axogen revenue
Axogen's revenue is $187.3 million.
What is Axogen's revenue?
- Axogen's revenue growth from 2010 to 2024 is 6,135.36%.
- Axogen has 297 employees, and the revenue per employee ratio is $630,767.
- Axogen's peak quarterly revenue was $49.4M in 2024(q4).
- Axogen peak revenue was $187.3M in 2024.
- Axogen annual revenue for 2023 was 159.0M, 14.74% growth from 2022.
- Axogen annual revenue for 2024 was 187.3M, 17.81% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Axogen historical revenue
Axogen's peak revenue was $187.3M in 2024. The peak quarterly revenue was $49.4M in 2024(q4).
Axogen's revenue increased from $3.0m in 2010 to $187.3M currently. That's a 6,135.36% change in annual revenue.
Axogen annual revenue
Axogen annual revenue over time
| Fiscal year / year | Axogen revenue |
|---|---|
| 2010 | $3.0M |
| 2011 | $4.8M |
| 2012 | $7.7M |
| 2013 | $10.9M |
| 2014 | $16.8M |
| 2015 | $27.3M |
| 2016 | $41.1M |
| 2017 | $60.4M |
| 2018 | $83.9M |
| 2019 | $106.7M |
| 2020 | $112.3M |
| 2021 | $127.4M |
| 2022 | $138.6M |
| 2023 | $159.0M |
| 2024 | $187.3M |
How accurately did Axogen's revenue projections match actual performance?
Axogen annual growth
Axogen saw the greatest revenue growth in 2015, when revenue increased by 62.52%.
Axogen had the lowest revenue growth in 2020, when revenue changed by 5.24%.
Axogen annual growth rate over time
| Year | Axogen growth |
|---|---|
| 2011 | 61%↑ |
| 2012 | 59%↑ |
| 2013 | 42%↑ |
| 2014 | 54%↑ |
| 2015 | 63%↑ |
| 2016 | 50%↑ |
| 2017 | 47%↑ |
| 2018 | 39%↑ |
| 2019 | 27%↑ |
| 2020 | 5%↑ |
| 2021 | 13%↑ |
| 2022 | 9%↑ |
| 2023 | 15%↑ |
| 2024 | 18%↑ |
Axogen quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Axogen quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2011 | - | $1.2M | $1.1M | $1.4M |
| 2012 | $1.7M | $2.0M | $2.0M | $2.0M |
| 2013 | $2.1M | $2.9M | $3.0M | $3.0M |
| 2014 | $3.1M | $4.2M | $4.7M | $4.8M |
| 2015 | $5.0M | $6.4M | $8.2M | $7.8M |
| 2016 | $8.1M | $10.4M | $11.2M | $11.4M |
| 2017 | $12.2M | $15.2M | $16.0M | $17.0M |
| 2018 | $17.3M | $20.6M | $22.7M | $23.4M |
| 2019 | $23.3M | $26.7M | $28.6M | $28.2M |
| 2020 | $24.3M | $22.1M | $33.4M | $32.5M |
| 2021 | $31.0M | $33.6M | $31.2M | $31.5M |
| 2022 | $31.0M | $34.5M | $37.0M | $36.2M |
| 2023 | $36.7M | $38.2M | $41.3M | $42.9M |
| 2024 | $41.4M | $47.9M | $48.6M | $49.4M |
Axogen jobs nearby
Do you work at Axogen?
Did Axogen meet its revenue projections?
Axogen financial information
| CEO | Ms. Karen L. Zaderej |
| Company Type | Public |
| Employees Number | 297 |
| Date Founded | 2002 |
| Headquarters | Alachua, Florida |
| Number of Locations | 5 |
| Revenue | $187.3M |
| Net Income | -$28,948,000 |
| Gross Proft | $142.0M (2024) |
| PE Ratio | -129.95 |
| Tax Rate | 0.1% |
| Market Capitalization | $1.3B |
| Total Assets | $195,387,000 |
| Ticker | AXGN |
Axogen jobs you might like
Axogen financing
Axogen received early financing of $12.1M on 2007-12-17.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $12.1M | 12/2007 |
| Debt Financing | $2.6M | 06/2009 |
| Debt Financing | $3.7M | 01/2011 |
| Debt Financing | $3M | 06/2011 |
| Post Ipo Equity | $18M | 08/2013 |
| Post Ipo Equity | $13M | 02/2015 |
| Post Ipo Equity | $17.5M | 08/2015 |
Axogen investors
| Investors | Security type |
|---|---|
| Cardinal Partners | Post Ipo Equity |
| DE NOVO VENTURES | Post Ipo Equity |
| Springboard Capital | Post Ipo Equity |
| Accuitive Medical Ventures | Post Ipo Equity |
| Essex Woodlands Health Ventures | Post Ipo Equity |
Axogen competitors
Axogen's top competitor, Zoetis, earned an annual revenue of $9.3B.
Axogen's smallest competitor is Invivoscribe with revenue of $6.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Ethicon | $62,256 | $4.9B | 11,000 | - |
| CoolSculpting | $73,648 | $342.1M | 686 | - |
| Molecular Devices | $85,783 | $150.0M | 631 | - |
| Zoetis | $87,092 | $9.3B | 11,300 | 293 |
| Cytori Therapeutics | $50,366 | $7.4M | 12 | - |
| RTI Surgical | $64,097 | $280.0M | 942 | 26 |
| Branch Medical Group | $42,923 | $580,000 | 9 | - |
| Fresenius Kabi | $44,731 | $800.0M | 72 | 94 |
| Immucor | $60,486 | $380.0M | 1,125 | - |
| CIMA Labs | $74,201 | $8.5M | 120 | 33 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Axogen highest paying jobs
Zippia gives an in-depth look into the details of Axogen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Axogen. The employee data is based on information from people who have self-reported their past or current employments at Axogen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Axogen. The data presented on this page does not represent the view of Axogen and its employees or that of Zippia.
Axogen may also be known as or be related to AXOGEN INC., AxoGen, AxoGen Inc, AxoGen, Inc., Axogen, Axogen Corporation and Axogen, Inc.